(Q44022961)

29 November 2017

title

Valproic acid therapy inducing absence status evolving into generalized seizures (English)

1 reference

29 November 2017

Eli Shahar

1

1 reference

29 November 2017

Jameel Andraus

series ordinal

2

1 reference

29 November 2017

Tally Sagie-Lerman

series ordinal

3

1 reference

29 November 2017

David Savitzki

series ordinal

4

1 reference

29 November 2017

publication date

1 May 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

26

1 reference

29 November 2017

issue

5

1 reference

29 November 2017

page(s)

402-404

1 reference

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900413-1

7 January 2021

Treatment of typical absence seizures and related epileptic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900413-1

7 January 2021

Acute intoxication with sodium valproate

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900413-1

7 January 2021

Valproate-induced epileptic tonic status

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900413-1

7 January 2021

Paradoxical response to valproic acid in a patient with a hypothalamic hamartoma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900413-1

7 January 2021

Absence seizures aggravated by valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900413-1

7 January 2021

Summary. Aggravation of seizures by antiepileptic drugs: what to do in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900413-1

7 January 2021

Seizures induced or aggravated by anticonvulsants

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900413-1

7 January 2021

Basic mechanisms of generalized absence seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900413-1

7 January 2021

Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900413-1

7 January 2021

Antiepileptic drug mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900413-1

7 January 2021

Failure of the antiepileptic drug valproic acid to modify synaptic and non-synaptic responses of CA1 hippocampal pyramidal cells maintained 'in vitro'

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900413-1

7 January 2021

Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900413-1

7 January 2021

Valproic acid intensifies epileptiform activity in the hippocampal pyramidal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900413-1

7 January 2021

Vigabatrin aggravates absences and absence status

1 reference

https://api.crossref.org/works/10.1016%2FS0887-8994%2801%2900413-1

7 January 2021

10.1016/S0887-8994(01)00413-1

Identifiers

DOI

1 reference

29 November 2017

1 reference